Pediatric Blood & Cancer, 1545-5009

Journal

1 - 10 out of 31Page size: 10

Publications

  1. 2020
  2. Published

    Pediatric cancer research: Surviving COVID-19

    Pamela Kearns, 18 Jun 2020, In : Pediatric Blood & Cancer. p. e28435

    Research output: Contribution to journal › Article

  3. E-pub ahead of print

    The COVID-19 pandemic: a rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI and St Jude Global

    Pamela Kearns, 13 May 2020, In : Pediatric Blood & Cancer. e28409.

    Research output: Contribution to journal › Article

  4. 2019
  5. Published

    Catalytic inhibition of KDM1A in Ewing sarcoma is insufficient as a therapeutic strategy.

    Susanne Gatz, Sep 2019, In : Pediatric Blood & Cancer. 66, 9, 9 p., e27888.

    Research output: Contribution to journal › Article

  6. Published

    Long-term analysis of children with metastatic neuroblastoma treated in the ENSG5 randomised clinical trial

    Pamela Kearns, 1 Apr 2019, In : Pediatric Blood & Cancer. 66, 4, 5 p., e27565.

    Research output: Contribution to journal › Article

  7. E-pub ahead of print

    Challenges and opportunities in the care of survivors of adolescent and young adult (AYA) cancers

    Michael Hawkins, 28 Feb 2019, In : Pediatric Blood & Cancer. 66, 6, e27668.

    Research output: Contribution to journal › Review article

  8. 2018
  9. E-pub ahead of print

    The utility of routine surveillance screening with magnetic resonance imaging to detect tumour recurrence/progression in children with high-grade central nervous system tumours

    Simon Stevens, Caroline Main, Andrew Peet, Keith Wheatley, Pamela Kearns & Jayne Wilson, 8 Nov 2018, In : Pediatric Blood & Cancer. 9 p., e27509.

    Research output: Contribution to journal › Article

  10. 2017
  11. E-pub ahead of print

    Investigating the heterogeneity of alkylating agents' efficacy and toxicity between sexes: A systematic review and meta-analysis of randomized trials comparing cyclophosphamide and ifosfamide (MAIAGE study)

    Keith Wheatley, 23 Jan 2017, In : Pediatric Blood & Cancer.

    Research output: Contribution to journal › Article

  12. 2016
  13. E-pub ahead of print

    A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia

    Pamela Kearns & 1 others, , 1 Dec 2016, In : Pediatric Blood & Cancer.

    Research output: Contribution to journal › Article

  14. 2015
  15. Published

    Chemotherapy responsiveness in a patient with multiply relapsed ameloblastic fibro-odontosarcoma of the maxilla

    Susanne Gatz, Nov 2015, In : Pediatric Blood & Cancer. 62, 11, p. 2029-2032 4 p.

    Research output: Contribution to journal › Article

  16. 2014
  17. Published

    Challenges for children and adolescents with cancer in Europe: The SIOP-Europe agenda

    Pamela Kearns, Sep 2014, In : Pediatric Blood & Cancer. 61, 9, p. 1551-1557 7 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 4 Next